Value of Histopathologic Examination of Uterine Products after First-Trimester Miscarriage

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Histopathological diagnosis  </td><td align="center">Number (percentage)</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">
                POC*</td><td align="center">537 (96.2%)</td></tr><tr><td align="left">No POC </td><td align="center">17 (3.0%)</td></tr><tr><td align="left">Arias-Stella reaction</td><td align="center">2 (0.4%)</td></tr><tr><td align="left">Partial mole </td><td align="center">1 (0.2%)</td></tr><tr><td align="left">Complete  mole</td><td align="center">1 (0.2%)</td></tr><tr><td align="center" colspan="2"><hr/></td></tr><tr><td align="left">Total</td><td align="center">558 (100%)</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><svg height="13.75" id="M4" style="vertical-align:-0.0pt" version="1.1" viewbox="0 0 7.7375002 13.75" width="7.7375002" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.012,-0,0,-.012,.062,5.525)"><path d="M471 153q-22 -15 -61 -13q-25 31 -45.5 49.5t-56.5 41.5q4 -71 28 -134q-17 -33 -42 -46q-24 12 -42 46q24 63 28 134q-36 -23 -56.5 -41.5t-45.5 -49.5q-36 -2 -61 13q0 28 19 59q65 10 130 43q-65 33 -130 43q-19 31 -19 59q22 15 61 13q25 -31 45.5 -49.5t56.5 -41.5
q-4 71 -28 134q17 33 42 46q24 -12 42 -46q-24 -63 -28 -134q36 23 56.5 41.5t45.5 49.5q36 2 61 -13q0 -28 -19 -59q-65 -10 -130 -43q65 -33 130 -43q19 -31 19 -59z" id="x2217"></path></g>
</svg>Products of conception.<br/></td></tr></table>

BioMed Research International

tab3

Table 3

Table 3: Value of Histopathologic Examination of Uterine Products after First-Trimester Miscarriage 